Company research / MIRM
Mirum Pharmaceuticals, Inc. (MIRM)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Mirum Pharmaceuticals, Inc. reported revenue of $521.31M. Revenue grew 54.7% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $618.07M.
Key ratios (year ended 2025-12-31)
-4.2%
Operating margin
-4.5%
Net margin
-7.4%
Return on year-end equity
54.7%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.